Product Browser

Last updated: 2017/8/20

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

MYOC 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00004653-T02
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-MYOC full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 57
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-MYOC antibody (H00004653-D01P) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00004653-T02
    MYOC transfected lysate.
    Western Blot
    QC Testing of H00004653-T02
    Lane 1: MYOC transfected lysate ( 57.00 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 4653
  • Gene Name:
  • MYOC
  • Gene Alias:
  • GLC1A,GPOA,JOAG,JOAG1,TIGR,myocilin
  • Gene Description:
  • myocilin, trabecular meshwork inducible glucocorticoid response
  • Gene Summary:
  • MYOC encodes the protein myocilin, which is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma. [provided by RefSeq
  • Other Designations:
  • OTTHUMP00000032681,mutated trabecular meshwork-induced glucocorticoid response protein,myocilin
  • RSS
  • YouTube
  • Linkedin
  • Facebook